By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Anergis 

BiopĂ´le III
Route de la Corniche 9B
  Epalinges  CH-1066  Switzerland
Phone: 41-21-651-92-20 Fax: 41-21-651-92-21


SEARCH JOBS


Industry
Biotechnology






Company News
Anergis Reports Positive Long-Term Clinical Efficacy Of Lead Compound AllerT 9/16/2014 11:33:21 AM
Anergis Appoints Dr. Vanya Beltrami As Director Product Development 6/3/2014 10:05:05 AM
Anergis To Present New COP Allergy Vaccine Data At European Academy of Allergology and Clinical Immunology Conference 2014 In Copenhagen 5/27/2014 1:34:43 PM
Anergis Completes Enrolment In The Long-Term Efficacy Trial Of Lead Compound AllerT 4/23/2014 11:26:33 AM
Phase 2b Results Of Anergis' Lead Compound Allert To Be Presented At 2014 American Academy of Dermatology Annual Meeting In San Diego 2/27/2014 8:14:27 AM
Anergis Closes Financing Round Totaling CHF 8 Million 2/5/2014 6:04:14 AM
Anergis Obtains Core Technology Patent In Japan 1/14/2014 9:43:42 AM
Immunology Data Further Underline the Positive Outcome of a Phase IIb Trial of Anergis' Birch Pollen Allergy Vaccine AllerT 10/21/2013 8:48:47 AM
Anergis Receives Swiss Life Sciences Prize 9/27/2013 9:55:35 AM
Anergis Reports Positive Phase IIb Data for Birch Pollen Allergy Vaccine AllerT 9/10/2013 9:37:46 AM
12
//-->